introduction genus lactobacillus recently reclassified new genus including emended genus lactobacillus comprises specie june present adaptability allowed colonize large number ecosystem including human body within gastrointestinal git vaginal tract human probiotic potential certain strain belonging genus widely studied sense ability lacticaseibacillus rhamnosus maintain gut homeostasis restore dysbiosis-mediated disease demonstrated previously within specie rhamnosus lgg one studied thus several beneficial effect associated clinical trial human intervention study well ability adhere intestinal epithelial layer interaction lactobacillus host git mediated molecule make bacterial surface turn determines adherence host tissue interaction microorganism ultimately survival interaction structure consequently effect produced bacteria reduced enhanced presence extracellular polysaccharide surrounding cell either remain attached bacterial surface synthesis may form capsule released surrounding medium form exopolysaccharides eps resulting ropy phenotype polymeric carbohydrate molecule composed series monosaccharide connected glycosidic bond according chemical composition divided homopolysaccharides hop heteropolysaccharides heps great diversity among lactic acid bacteria lab heps could vary composition structure molecular mass production characteristic strongly contribute specific characteristic solubility rheological property physicochemical biological functionality unlike covalently attached cell wall eps secreted growth medium loosely attached cell surface diversity bacterial eps structure vast since property eps depend structure spectrum technological functional property eps broad eps produced lab contribute textural property dairy product eps also suggested influence bacteria-host interaction especially affecting host cell mucosa adhesion bacterial-mediated immunomodulation eps lactobacillus reported large number pharmacological application immunomodulatory blood cholesterol-reducers nutraceuticals anti-allergic etc eps produced probiotic bacteria reported control inflammatory mechanism immune cell increase colonisation gut modulate intestinal microbiota indeed eps may serve source nutrient resident microbiota previous study either purified eps eps-producing non-producing strain showed ability eps mediate microbe–microbe interaction however contribution eps overproduction lactobacillus strain relation host effect largely underexplored probiotic strain may represent future potential strategy treatment prevention gut dysfunction significant impact human health case rhamnosus cncm-i first described grompone excellent protector oxidative stress anti-inflammatory effect subsequently notable protector intestinal barrier function murine model inflammation protection associated maintaining modulated globular cell mucus layer modulated countering change local systemic lymphocyte furthermore rhamnosus cncm i-3690 putative surface adhesins among spafed pili previously found key beneficial effect host present study analysed contribution eps production anti-inflammatory property rhamnosus cncm i-3690 selected high eps-producer lower producer derivate analysed murine mode low-grade inflammation vivo host gut microbiota interaction material method bacterial strain cell line culture condition rhamnosus cncm i-3690 variant grown man rogosa sharpe medium difco usa human caco-2 atcc port ht-29 htb-38 lgc standard ht-29 mtx cell line used perform assay according standard protocol caco-2 cell grown dulbecco modified eagle minimum essential medium dmem 7.4 invitrogen waltham usa supplemented inactivated fetal bovine serum fbs lonza levallois-perret france glucose penicillin/streptomycin glutamine invitrogen non-essential amino acid solution invitrogen ht-29 ht-29 mtx cultured condition without non-essential amino acid isolation rhamnosus cncm i-3690 variant affected eps production variant altered eps production isolated using todd hewitt broth 0.5 yeast extract low agar concentration 0.03 extent free displacement bacteria medium depends viscosity semi-liquid medium eps production consequently eps-producing variant isolated slower sedimenting derivative eps-negative variant faster sedimenting derivative quantification eps production quantify eps production bacteria grown durapore membrane filter 0.22 millipore placed agar plate bacteria harvested resuspended milliq bacterial suspension adjusted heated min inactivate potential enzyme able degrade polysaccharide centrifuged min 20,000 supernatant recovered eps precipitated ethanol previously described total neutral sugar amount eps extract expressed glucose equivalent quantified glucose standard genomic dna extraction genomic dna extracted overnight culture first step enzymatic lysis following cocktail mutanolysin 233.3 µ/ml sigma lysostaphin 13.3 µ/ml sigma lysozyme mg/ml sigma followed incubation rnase mg/ml thermofisher proteinase mg/ml euromedex dna purification performed dna extraction kit genomic dna buffer set genomic tip qiagen according manufacturer instruction dna re-suspended buffer concentration measured nanodrop nanodrop thermoscientific genome analysis genome sequenced eurofins using nanopore gridion platform flow cell version r9.4.1 oxford nanopore technology assembled using software flye http medaka http presence plasmid verified using plasmidfinder http genome annotated using rast-tk bv-brc http eggnog-mapper http variation reference genome variant identified using two approach large variation verified using artemis comparison tool v18.1.0 http snp identified using tool variation analysis bv-brc http keeping variation coverage gene sequence aligned visualized using jalview v2.11.2.5 http muscle v3.8.31 alignment algorithm vitro immuno-modulatory permeability adhesion test anti-inflammatory property rhamnosus derivative determined measuring capacity suppress secretion pro-inflammatory il-8 tnf-α stimulated ht-29 cell briefly suspension differentiated ht-29 cell seeded well plate medium described incubated day air atmosphere confluence 1.83 cells/well medium changed daily twenty-four hour co-culture serum concentration medium reduced co-culture medium replaced fresh medium supplemented sfv ng/ml recombinant human tnf-α preprotech usa stimulate il-8 production bacterial suspension added multiplicity infection moi 1:40 permeability assay caco-2 cell line co-cultured bacterial strain briefly suspension caco-2 cell plated transwell semi-permeable filter support diameter well polystyrene membrane 0.4 pore costar corning trans-epithelial electrical resistance teer reading ohm teer measured cfu bacterial suspension per well added onto apical surface three hour later cell stimulated adding ng/ml tnf-α basolateral medium plate incubated teer measured experiment performed duplicate result presented ratio ratio=\frac teer\ treatment\ 24/teer\ treatment\ teer\ control\ 24/teer\ control\ lastly adhesion capacity bacterial strain tested following procedure described turpin slight modification briefly suspension ht-29 mtx cell seeded 24-well tissue culture plate nunc cultivated confluence cell left mucus production total day medium changed daily monolayer infected multiplicity infection moi 1:50 incubation anaerobic condition monolayers washed three time phosphate-buffered saline 7.2 epithelial cell lysed triton x-100 sigma chemical company louis water direct sample respective dilution plated onto agar plate incubated determine number adhered cfus murine model low-grade inflammation male c57bl/6 mouse janvier genest saint isle france maintained specific pathogen-free spf condition animal care facility national institute agricultural research ierp inra jouy-en-josas france minimum one week prior experimentation mouse induced intestinal dysfunction using dnbs previously described low-grade inflammation generated two intra-rectal injection dnbs dissolved etoh mg/kg mg/kg respectively anesthesia 21-days recovery period fig mouse anesthetized using intraperitoneal i.p injection 0.1 ketamine imalgene merial france 0.06 xylazine rompun bayer france control mouse received vehicle day firth injection mouse administered daily containing cfu viable bacteria cncm i-3690 strain alone total mouse employed study mouse per group spliced two experiment mouse per group experiment realized experiment performed accordance european community standard animal care three rule approved relevant local committee comethea ethic committee performed also compliance arrive relevant guideline different inflammatory parameter macroscopic colonic score weight loss cytokine concentration myeloperoxidase mpo activity marker degree infiltration polymorphonuclear neutrophil measured previously described vivo permeability determined using fluorescein-conjugated dextran fitc-dextran 3000–5000 fd-4 sigma-aldrich endpoint previously described histological immunohistochemical analysis according standard protocol sample fixed paraformaldehyde carnoy buffer dehydrated embedded paraffin histological analysis carried tissue section block cut leica rm2265 microtome mounted adhesive microscope slide superfros ultra plus thermoscientific sample stained hematoxylin–eosin safran periodic acid-schiff alcial blue mucin-2 muc2 detection section deparaffinized rehydrated rinsed according standard protocol sample incubated sequentially protein block dako agilent technology primary antibody µl/ml mucin rabbit polyclonal igg santa cruz biotechnology secondary antibody ng/ml alexafluor goat red anti-rabbit igg invitrogen thermofischer scientific diluted diluent dako agilent technology section treated trihydro-chloride trihydrate 0.5 mg/ml hoechst invitrogen thermofischer scientific subsequently slide mounted using fluorescent mounting medium dako agilent technology tissue visualized using high-capacity digital slide scanner 3dhistech ltd. panoramic case viewer software 3dhistech ltd. transcriptome analysis transcriptome analysis 20–30 colon sample processed rneasy mini kit qiagen previously described extract total rna rna quantity quality determined using nanodrop lent expert bioanalyzer respectively reference design complete dye-swap including biological replicates used compare dnbs-challenged mouse total chip agilent sureprint 60k microarrays agilent technology france raw data extracted microarray image using agilent feature extraction software pre-processed using package agilp obtained bioconductor http probe detected sample excluded analysis normalization raw intensity done quantile normalization method normalized data adjusted batch effect using combat method differential expression analysis determined mean empirical bayesian test anova/benjamini hochberg multiple correction test applied identify significant gene considering p-value 0.05 followed filtering expression level 1.25 cut-off analyze pathway generate data display selected gene list log ratio p-value data loaded ingenuity pathway analysis ipa elucidate difference taxon abundance different clustering variable anova/tukey kramer post hoc test false discovery rate fdr applied considering significant difference p-value lower 0.05 q-value 0.3 transcriptome data submitted geo accession number gse101411 reverse transcription quantitative real-time pcr qpcr reverse transcription performed applied biosystems high capacity cdna reverse transcription kit thermofisher france reverse-transcription total rna performed resulting cdna quantified using nanodrop thermofisther scientific inc. france sample diluted 10x duplicated subjected quantitative real-pcr qpcr step one plus detection system applied mix reaction developed final volume consisted 12.5 roxsybr master mix blue dttp takyon eurobio france primer qiagen-rt qpcr assay diluted cdna value expressed relative fold difference normalized housekeeping gene gapdh using −δδct method procedure performed according manufacturer instruction analysis lymphoid population mesenteric lymphoid nod mln gently extruded μm-mesh nylon cell strainer isolate mononuclear cell cell suspended dulbecco modified eagle medium dmem supplemented fbs -glutamine u/mg penicillin µ/mg streptomycin lonza levallois-perret france flow cytometry analysis aliquot –10 cell per sample labelled anti-cd3-fict anti-cd4-percp anti-tbet-apc anti-gata3-pe according manufacturer instruction ebioscience cell analyzed using flow cytometry accuri cflow sampler software bioscience described previously gut microbiota analysis fresh fecal sample collected two time point d13 d23 stored dna obtained via mechanical lysis fastprep fp120 thermosavant phenol/chloroform-based extraction previously described amplification performed using primer v3-v4 rrna forward cctacgggnggcwgcag reverse gactachvgggtatctaatcc sample loaded flow cell illumina miseq 300pe sequencing platform accordance manufacturer instruction adaptation qiime v2.0 package used analyze sequence data caporaso briefly read pair demultiplexed trimmed merged using qiime merged read window base ambiguous base minimal length retained taxonomic assignment performed using rdp classifier silva_ silva_138 database result sequence aggregated different taxonomic level read eukaryotic assignment well read low relative abundance 0.0005 sample excluded downstream analysis read eukaryotic assignment well read low relative abundance 0.0005 sample excluded downstream analysis analysis performed using version 3.6.0 sample rarefied using phyloseq library package vegan function richness used calculate alpha diversity metric shannon difference change alpha-diversity bray–curtis dissimilarity baseline evaluated using mann–whitney test specific comparison without adjustment multiple testdeseq2 package version 1.26.0 used identify genus differentially abundant within group group group group day mice_id significant fold-change difference dos time point evaluated negative binomial model-based wald test implemented deseq2 fdr 0.1 sequence deposited ena accession number prjeb56457 statistical analysis statistical data analysis non-parametric kruskal–wallis test followed dunn multiple comparison post hoc test employed using graphpad software jolla usa plot presented mean sem result generation putative eps derivative cncm i-3690 isolate rhamnosus cncm i-3690 derivative various eps production level used method based differential sedimentation bacterial growth semi-liquid medium condition viscosity medium restricts free movement bacteria sedimentation represents principal mean displacement bacteria display autonomous motility property starting form colony non-eps-producing strain medium simultaneous growth sedimentation result streaked colony contrariwise eps-producing bacteria condition trapped extracellular agar matrix produced eps sediment consequently forming round colony furthermore possible observe select variant escaping immobilization form faster sedimenting root round colony method adapted previously select capsule polysaccharide-negative mutant rhamnosus cncm i-3690 form short chain thus sediment relatively slowly condition increase efficiency screening procedure first isolated faster sedimenting variant named fig applying procedure isolated three slower sedimenting derivative condition strain fig three derivative expressed markedly increased ropy phenotype grown colony agar plate phenotype usually considered indicative eps production addition derivative isolated seven variant faster sedimenting medium strain agar plate appeared non-ropy derivative therefore potentially lost ability secrete eps fig figure scheme isolation rhamnosus cncm i-3690 derivative affected eps production full size image putative eps variant cncm i-3690 showed altered anti-inflammatory protective property vitro anti-inflammatory property cncm i-3690 variant strain tested vitro measuring ability reduce production il-8 tnf-α stimulated ht-29 cell expected strain cncm i-3690 co-incubated cell line statistically significant reduction il-8 production fig similarly non-ropy variant tested showed anti-inflammatory activity contrast ropy one show effect noteworthy activity variant first one characterised ropy phenotype lower anti-inflammatory activity second one opposite figure immunomodulatory protective activity rhamnosus cncm i-3690 variant immunomodulatory property measured ability strain regulate production interleukin il-8 ht-29 cell stimulated tnf-α protective effect evaluated measuring trans-epithelial resistance caco-2 cell presence bacterial strain significance 0.05 full size image addition studied protective effect bacterial strain intestinal barrier measuring trans-epithelial electrical resistance teer tnf-α stimulated caco-2 cell fig previously reported cncm i-3690 showed significant protective effect non-ropy variant slight significant protective effect observed test however ropy one presented significantly lower protective ability wild-type variant over-producer eps variant rhamnosus cncm i-3690 reduced adhesion capacity ropy phenotype often consequence increased production eps bacteria since strain expressed ropy phenotype lost performed eps quantification experiment eps produced bacteria grown filter agar plate isolated previously total neutral sugar eps extract quantified result presented fig confirm strain indeed produce almost twofold higher amount eps compared either strain eps production low strain result confirm eps-overproducing derivative rhamnosus cncm i-3690 derivate eps-negative variant figure relative eps production rhamnosus cncm i-3690 derivative full size image variant selected analysis adhesion property tested mucus producer ht-29 mtx cell line observed significant reduction adhesion capacity variant whereas variant slightly increased adhesion cell line compared fig figure percentage adhesion ht-29-mtx cell eps-overproducer underproducer variant comparation wild-type rhamnosus cncm i-3690 significance 0.05 full size image identification mutation leading eps overproduction dna nucleotide sequence determination determined dna nucleotide sequence strain cncm i-3690 faster sedimenting derivative eps overproducing variant strain eps-negative variant strain analysis sequence mutation occurring strain identified table found strain mutation present coding region gene lace system lactose-specific iib component lacg 6-phospho-beta-galactosidase lact beta-glucoside bgl operon antiterminator epsd tyrosine-protein kinase however lace lacg lact gene incomplete presumably inactive fig therefore consider mutation seems relevant investigated phenotype eps production anti-inflammatory property appeared epsd gene gene located cluster responsible polysaccharide synthesis encodes regulatory tyrosine kinase involved regulation eps streptococcus thermophilus pneumoniae strain mutation epsd resulted amino acid change ser leu position presumed mutation result increased eps production since strain derivative mutation epsd additional mutation leu arg position gene probably resulting inactivation epsd subsequent abolishing eps production fig note variant selected faster sedimenting derivative strain property needed efficient selection slower sedimenting derivative appeared strain acquired large deletion terminus part chromosome deletion fragment probably responsible selected faster sedimenting phenotype due forming shorter chain fig since derivative differ eps production anti-inflammatory property carry deletion consider relevant mentioned phenotype fig preliminary test ht-29 caco-2 cell fig ropy strain non-ropy derivative chosen characterization eps over-producer variant reduces protective effect cncm i-3690 wild type low-grade inflammation murine model murine model chronic dnbs-induced low-grade inflammation used analyse impact eps cncm i-3690 effect test eps variant fig treatment variant improved colonic macroscopic score showing statistical difference rhamnosus cncm i-3690 fig treatment furthermore variant like strain reduced level cytokine particular level ifn-γ ifn-β 0.05 increased level il-10 fig effect observed strain showed similar value untreated group similarly fd4 permeability increased inflamed control 7292-treated mouse due dnbs challenge unaltered either control group cncm-i 7358-treated group fig figure evaluation macroscopic score dinitro-benzene sulfonic acid dnbs low grade colitis model treatment eps variant comparation wild-type rhamnosus cncm i-3690 significance 0.05 full size image figure colonic interleukin level low grade dinitro-benzene sulfonic acid dnbs colitis model treatment eps variant comparation wild-type rhamnosus cncm i-3690 significance 0.05 full size image figure measure vivo gut permeability dnbs low grade murine model treatment eps variant comparation wild-type rhamnosus cncm i-3690 significance 0.05 full size image eps over-producer variant lost capacity improve colonic barrier permeability increasing mucus production restoring goblet cell population rhamnosus cncm i-3690 known restore goblet cell population mucus production altered dnbs low-grade colitis model reason tested ability variant restore mucus layer mucus-producing cell shown fig expected mucus layer thickness significantly altered untreated group presented thinner layer control cncm i-3690 7358-treated group 0.05 effect could counteracted 7292-treated group showed significant difference untreated mouse stained alcian blue periodic acid-schiff method reveals acid neutral mucopolysaccharide respectively fig percentage labelled either lower untreated group cncm i-3690 7358-treated group 0.05 presented significant difference among 7292-treated group showed lower proportion suggesting loss ability restore level figure effect treatment eps-overproducer underproducer variant comparation wild-type rhamnosus cncm i-3690 mucus layer globet cell abundance ab-staining test dnbs low grade murine model significance 0.05 full size image mesenteric lymph node mln population show significant difference among eps variant strain similarly analyse ability eps variant maintain beneficial effect strain cd3 cell well t-bet gata-3 subpopulation th1 th2 respectively analysed mlns previously described value higher untreated group control one 0.05 cncm i-3696 able restore normal situation fig regarding variant significant difference found compared cncm i-3690 strain fig figure immunological activity mln cell mln cell positive cd3 cd4 t-bet gata-3 detected using flow cytometry significance 0.05 full size image transcriptomic analysis reveals variant positively regulates gene related inflammatory function negatively regulates protective one transcriptomic analysis revealed differential expression gene 52.37 up-regulated 7292-treated mouse treated one 43.09 up-regulated first one 3690-treated mouse 0.05 fig ipa analysis specific signaling pathway modulated variant showed derivative able significantly upregulate 0.05 great number related-immune response pathway compared untreated mouse table figure venn diagram showing number unique shared upregulated downregulated gene identified via ipa murine model treatment variant gene number compared modulated treatment wild-type rhamnosus cncm i-3690 not-treated mouse administered vehicule significance 0.05 full size image table gene modulated variant versus wild-type cncm i-3690 major modulated pathway modulated variant identified via ingenuity pathway analysis software full size table variant increased nf-κb il-6 il-8 signaling also increase macrophage derived-activity activating different related-pathways fcγ receptor-mediated phagocytosis macrophage monocyte ccr5 signaling production nitric oxide reactive oxygen specie macrophage addition th1 pathway analysis also revealed increase pathway involving lymphocyte ctla4 signaling cytotoxic lymphocyte protein kinase lymphocyte besides increase integrin signaling important pathway erk/mapk signaling role jak1 jak3 cytokine signaling also activated mouse treated variant compared untreated mouse lastly compared sample 7292-treated mouse treated strain down-regulation p-53 pathway observed well up-regulation nitric oxide signaling table effect cncm i-7292 host independent gut microbiota finally given effect eps over-producering variant host examined whether effect might mediated gut microbiota gut microbiota mouse dominated bacteroidota genus within muribaculaceae family firmicutes fig studied effect dnbs injection rhamnosus cncm i3690 derivative gut microbiota composition compared specifically effect eps variant cncm i-3690 based overall structure difference alpha-diversity genus based -shannon index analyzed group fig mann–whitney 0.05 bray–curtis dissimilarity day13 tended higher mouse exposed dnbs compared mann–whitney 0.09 difference group treated cncm i-3690 compared dnbs variant compared cncm i-3690 fig last differential analysis using deseq2 analysis showed decrease genus lachnoclostridium compared cncm i-3690 time fdr 0.09 taken together result indicate minor effect gut microbiota suggesting probably direct effect host fig figure effect dnbs eps variation gut microbiota genus-based shannon index mann–whitney test within-mice bray–curtis dissimilarity d13 mann–whitney test differentially abundant genus identified using deseq2 based between-group effect adjustment d13 fdr 0.1 red indicates higher abundance first group d23 versus d13 compared second group d23 versus d13 full size image discussion extracellular polysaccharide produced probiotic microorganism might play prominent role therapeutical activity present study evaluated part production secreted eps beneficial effect host rhamnosus strain cncm i-3690 described previous study restorer intestinal barrier murine model selected analysed vitro ten variant strain altered eps production using ropy phenotype readout ropy phenotype commonly associated high eps production well characteristic sugar composition subsequently two strain opposite phenotype regard ropiness selected vivo analysis eps quantification indicated produced increased amount eps whereas eps production low strain whole genome dna sequence analysis indicated acquired mutation epsd gene acquired second mutation gene since epsd shown encode regulatory tyrosine kinase involved regulation eps thermophilus pneumoniae localization mutation gene coherent eps production level result vitro test showed non-ropy variant conserved anti-inflammatory effect strain contrast variant characterized ropy phenotype lost furthermore ropy variant doe display beneficial effect produced strain also vivo model sense yılmaz previously reported pro-inflammatory profile ropy eps produced lactiplantibacillus plantarum strain stimulation il-12 tnf-α addition limited stimulation anti-inflammatory cytokine ht-29 cell contrast another study shown protective effect ropy eps-producing strain bifidobacterium longum subsp longum ys108r dss-induced colitis model maintenance mucosal barrier modulation gut microbiota another example keystone commensal bacterium faecalibacterium prausnitzii eps described anti-inflammatory modulating intestinal immunity also showing protective effect model chronic moderate severe dnbs-induced colitis eps interact receptor located intestinal epithelium acting effector molecule elicit immune response however vivo study performed different eps-producing lactobacillus johnsonii strain determined mutant inactivated eps gene exhibited longer residence time animal gut lebeer previously demonstrated loss eps production rhamnosus improved vitro adhesion caco-2 cell however also shown presence eps surrounding strain improved vivo performance allowing strain persist longer period eps protection antimicrobial peptide ll-37 study support hypothesis activity developed strain depends largely composition eps also amount produced accordingly polymer eps could avoid display several bacterial surface molecule involved adhesion also act buffer host immune defense case pili structure fundamental beneficial effect several probiotic commensal bacteria pili regulates host cell gene involved cell proliferation inflammation colon note inactivation spaf gene rhamnosus cncm-i resulted loss effect strain using vitro approach first observed eps overproduction resulted loss anti-inflammatory effect similarly mouse induced low-grade inflammation treated overproducer variant fully recover treated colonic permeability colonic cytokine level population remained altered colonic transcriptome analysis revealed treatment variant changed expression large number gene inflammation pathway frequently controlled nf-κb master regulator gene transcription result transcriptomic analysis showed increase nf-κb signaling 7292-treated mouse resulting exacerbated inflammation activation canonical nf-κb pathway associated rapid acute production diverse pro-inflammatory mediator il-6 il-8 cytokine study signaling cytokine increased 7292-treated mouse respect untreated mouse previously reported inactivation pathway administration rhamnosus cncm i-3690 evidence suggests macrophage cell-derived cytokine play key role amplification perpetuation inflammatory response observed increase macrophage activity activation different pathway among found fcγ receptor-mediated phagocytosis ccr5 signaling production nitric oxide reactive oxygen specie besides also observed increase th1 pathway th1 cell essential protecting pathogen mainly produce interferon ifn tumor necrosis factor tnf able activate macrophage cytotoxic cd8 cell activation promotes clearance intracellular pathogen transcriptomic result confirm obtained colonic cytokine analysis observed increase proinflammatory response production ifn-γ ifn-β tnf-α cytokine mouse administered overproducing eps variant contrast production il-10 important immunoregulatory anti-inflammatory cytokine involved preservation intestinal mucosal barrier suppressing protein misfolding endoplasmic reticulum stress inhibited mouse administered respect whose response high previously reported therefore surprising mouse treated variant significantly flower number variant reaching similar value untreated mouse cell responsible mucus production altering number implies direct effect mucus layer consequently lead permeability disfunction observed study underlying pathobiology gut inflammation includes increase infiltrating gut-homing lymphocyte lymphocyte homing typically tightly regulated stepwise process involving multiple integrins transcriptomic analysis revealed first increase pathway involving lymphocyte ctla4 signaling cytotoxic lymphocyte protein kinase lymphocyte secondly also increase integrin signaling lastly important inflammation-related pathway erk/mapk signaling role jak1 jak3 cytokine signaling also upregulated pathway activated cytokine secreted inflammatory response first activation protein kinase mapk pathway binding cytokine receptor tyrosine kinase also activates janus kinase-3 jak-3 signal transferred jak-3 dna nucleus cell chain kinase ultimately activating extracellular receptor kinase erk/mapk context previosuly reported higher activity pathway mouse treated rhamnosus cncm i-3690 δspaf mutant lacking pili structure comparing strain none pathway altered mouse treated rhamnosus cncm i-3690 transcriptome analysis sample 7292-treated mouse showed down-regulation p-53 pathway well up-regulation nitric oxide signaling compared p-53 gene encodes protein responsible cell cycle regulation dna repair apoptosis overexpression p-53 predicts risk colorectal neoplasia inflammatory bowel disease ibd turn nitric oxide production increased ibd tissue also evidence level synthase enzyme inos -derived correlate well disease activity ulcerative colitis type ibd .overall transcriptomic analysis revealed increase inflammation-related signaling pathway 7292-treated mouse relative untreated mouse thus confirming result obtained vitro low-inflammation murine model last evaluated effect eps over-production host could mediated gut microbiota previous study suggest eps could fermentable substrate gut microbe according overall structure alpha beta-diversity difference group differential analysis revealed minor effect over-expression strain suggesting over-expressing strain exert rather direct host gut microbiota modulation conclusion work show eps overproduction negatively affect beneficial property strain demonstrated eps major effector bacterial host crosstalk effect might specie even strain specific role eps possible interference pili function analyzed better decipher gut microbiota- host crosstalk develop appropriate strategy use probiotic treatment/prevention intestinal inflammation